Cancer Australia is seeking comment on a new draft clinical practice guideline Recommendations for the management of breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation. The guideline provides health professionals with information to assist them in making management recommendations for improved patient outcomes.
The guideline is based on a systematic review of the evidence published from January 2001 to April 2012.
The draft guideline is available for public comment during the external consultation period 11 September – 23 October.
Should you have any queries in relation to this invitation please contact Mr Tamar Dalton on telephone: 02 9357 9479 or email email@example.com